Next Article in Journal
Guilt, Shame and Compassionate Imagery in War: Traumatized German Soldiers with PTSD, a Pilot Study
Next Article in Special Issue
The Dual Role of Neutrophils in Inflammatory Bowel Diseases
Previous Article in Journal
The Influence of Parental Emotional Neglect on Assault Victims Seeking Treatment for Depressed Mood and Alcohol Misuse: A Pilot Study
Open AccessReview

Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?

1
Institute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK
2
Lung Function and Sleep, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TT, UK
3
Respiratory Research, Research and Development, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TT, UK
*
Author to whom correspondence should be addressed.
Academic Editors: Christophe Dubois and Laurence Panicot-Dubois
J. Clin. Med. 2016, 5(10), 89; https://doi.org/10.3390/jcm5100089
Received: 24 August 2016 / Revised: 17 September 2016 / Accepted: 20 September 2016 / Published: 11 October 2016
(This article belongs to the Special Issue Neutrophil Functions: From Immunity to Disease)
Drug classes used in the treatment of Chronic Obstructive Pulmonary Disease (COPD) have not changed for many years, and none to date have shown disease-modifying activity. Statins are used to help reduce cardiovascular risk, which is high in many patients with COPD. Their use has been associated with improvements in some respiratory manifestations of disease and reduction in all-cause mortality, with greatest reductions seen in patients with the highest inflammatory burden. The mechanism for these effects is poorly understood. Neutrophils are key effector cells in COPD, and correlate with disease severity and inflammation. Recent in vitro studies have shown neutrophil functions are dysregulated in COPD and this is thought to contribute both to the destruction of lung parenchyma and to the poor responses seen in infective exacerbations. In this article, we will discuss the potential utility of statins in COPD, with a particular emphasis on their immune-modulatory effects as well as presenting new data regarding the effects of statins on neutrophil function in vitro. View Full-Text
Keywords: neutrophil; inflammation; COPD; statins; chemotaxis; simvastatin neutrophil; inflammation; COPD; statins; chemotaxis; simvastatin
Show Figures

Figure 1

MDPI and ACS Style

Walton, G.M.; Stockley, J.A.; Griffiths, D.; Sadhra, C.S.; Purvis, T.; Sapey, E. Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD? J. Clin. Med. 2016, 5, 89.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop